Papers In Press, published online ahead of print March 24, 2008
J. Biol. Chem, 10.1074/jbc.M707494200
Submitted on September 6, 2007
Accepted on March 24, 2008
Aberrant folding of pathogenic parkin mutants: Aggregation versus degradation
Julia S. Schlehe, A. Kathrin Lutz, Anna Pilsl, Kerstin Lämmermann, Katja Grgur, Iris H. Henn, Jörg Tatzelt, and Konstanze F. Winklhofer
Biochemistry/Neurobiochemistry, Ludwig-Maximilians-University Munich, Munich 80336
Corresponding Author: konstanze.winklhofer{at}med.uni-muenchen.de
Loss-of-function mutations in the parkin gene (PARK2) are responsible for the majority of autosomal recessive Parkinson's disease (PD). A growing body of evidence indicates that misfolding and aggregation of parkin is a major mechanism of parkin inactivation, accounting for the loss-of-function phenotype of various pathogenic parkin mutants. Remarkably, also wildtype parkin is prone to misfolding under certain cellular conditions, suggesting a more general role of parkin in the pathogenesis of PD. We now show that misfolding of parkin can lead to two phenotypes: the formation of detergent-insoluble, aggregated parkin, or destabilization of parkin resulting in an accelerated proteasomal degradation. By combining two pathogenic parkin mutations, we could demonstrate that destabilization of parkin is dominant over the formation of detergent-insoluble parkin aggregates. Furthermore, a comparative analysis with HHARI, an E3 ubiquitin ligase with a RBR domain highly homologous to that of parkin, revealed that folding of parkin is specifically dependent on the integrity of the C-terminal domain, but not on the presence of a putative PDZ-binding motif at the extreme C-terminus.